Brand name
Edurant Ped, the original
We didn’t find a savings card or cash price from Edurant Ped’s maker. Ask the pharmacy for Edurant Ped’s cash price. With insurance, ask what your plan charges.
Generic name: rilpivirine
Used for: HIV
Ask for the cash price
Edurant Ped
We didn’t find one.
Edurant Ped, the original
We didn’t find a savings card or cash price from Edurant Ped’s maker. Ask the pharmacy for Edurant Ped’s cash price. With insurance, ask what your plan charges.
There isn’t one.
We didn’t find one.
EDURANT and EDURANT PED are a human immunodeficiency virus type 1 (HIV-1) specific, non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve patients 2 years of age and older and weighing at least 14 kg with HIV-1 RNA less than or equal to 100,000 copies/mL..
Limitations of Use:
EDURANT is indicated in combination with VOCABRIA (cabotegravir), for short-term treatment of HIV-1 infection in adults and adolescents 12 years and older and weighing at least 35 kg who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
Source: the FDA label for Edurant Ped (Janssen Products, LP), August 28, 2025. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/edurant-ped/